"Twin Cities Researchers Pioneer Non-Surgical Heart Device"
Twin Cities researchers have played a significant role in the development of the TriClip device by Abbott, which has received FDA approval as an alternative to open-heart surgery for treating tricuspid regurgitation. The minimally invasive procedure involves placing a small TriClip in the heart to stop valve leakage, offering significant benefits to patients. The Minneapolis Heart Institute Foundation led the clinical trial for the device, and patients have reported positive impacts on their quality of life. Dr. Santosh Prabhu, a leader in the research and development, believes the device will have a substantial global impact, with ongoing efforts to further advance its use for future patients.